Clinical Trials Browser

Phase 1/2 × INDUSTRY × marizomib × Clear all

NCT02330562 2022-06-08

Stage 1: Marizomib + Bevacizumab in WHO Gr IV GBM; Stage 2: Marizomib Alone; Stage 3: Combination of Marizomib and Bevacizumab

Phase 1/2 Completed

121 enrolled 27 charts

Brain Neoplasms, Glioblastoma, Glioma, Gliosarcoma